Zenyatta Ventures Ltd.; Motion for Injunction by First Nation community adjourned to May 20 While Drilling Continues

Zenyatta Ventures Ltd. (ZEN : TSX Venture) (“Zenyatta” or “Company”) announces that the Motion for Injunction by Constance Lake First Nation (“CLFN”) in Ontario Superior Court on Friday April 29 was adjourned until Wednesday May 11 and is adjourned again until Friday May 20. In the meantime, the Judge has ordered that CLFN, Zenyatta and Ontario (“Crown”) carry on further consultation while drilling continues on the current claim blocks. Discussions between Zenyatta, CLFN and the Crown took place on May 5 and 6 and will continue this week. Under the Court Order, Zenyatta can move a drill to another specified claim block if it desires. The Court expects that CLFN will have completed its archaeological report and traditional practice consultation respecting all sites for Zenyatta's current exploration program by May 20. If the parties do not reach a consensus in the interim, the Motion for an Interim Injunction will be argued on Friday May 20 before Justice Lederman in Ontario Superior Court. Zenyatta remains committed to on-going good faith dialogue with the Crown and CLFN respecting the community's concerns but will defend its rights and interests. The Company’s Board and management are optimistic that an agreement can be reached with CLFN. To find out more on Zenyatta Ventures Ltd., please visit our website at www.zenyatta.ca or contact the Company at info@zenyatta.ca or Tel. 807-346-1660. This news release may contain forward-looking statements and is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the Company’s forward-looking statements and expectations. The forward-looking information contained herein is given as of the date hereof and the Company assumes no responsibility to update or revise such information to reflect new events or circumstances, except as required by law. The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.
  • Share

About Zentek Ltd.

Zentek is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection and treatment. Zentek is currently focused on commercializing ZenGUARD™, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.

To find out more about Zentek Ltd., please visit our website at www.zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR profile at www.sedar.com.

Forward-Looking Statements

This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information:

Tyler Dunn

Director, Marketing & Communications

tdunn@zentek.com

Subscribe for Updates

Interested in recieving press releases directly to your inbox? Subscribe to Zentek's mailing list for all the latest news.